FOOD AND DRUG ADMINISTRATION

Amendments

Agriculture, rural development, FDA, and related agencies programs: authorizing appropriations (H.R. 3603), S8438, S8440, S8446, S8448, S8458, S8463, S8464, S8465, S8483, S8484, S8486, S8487, S8488 [22JY], S8540, S8541, S8542, S8543, S8544, S8545, S8546, S8548, S8551, S8552, S8577, S8578, S8579, S8580 [23JY], S8586, S8594, S8611, S8613, S8614, S8615, S8616, S8645, S8646 [24JY], H6118 [10JN], H6176, H6177, H6181, H6184 [11JN], H6192, H6198, H6199, H6201, H6211, H6212 [12JN]

Animals: improve animal drug approval process (S. 773), S11189 [24SE]

Appointments

Conferees: H.R. 3603, agriculture, rural development, FDA, and related agencies programs appropriations, S8616 [24JY], H8671 [30JY]

Articles and editorials

Consensus on Teen Smoking, H916 [26JA]

Costly Oversight—Fine Print in GATT Law Could Cost Zantac Users Millions, S3582 [18AP]

FDA Can Work Better, S9550 [2AU]

Zantac Windfall, S3580 [18AP]

Bills and resolutions

Agriculture, rural development, FDA, and related agencies programs: authorizing appropriations (see H.R. 3603), H6040 [7JN]

———authorizing appropriations (H.R. 3603), consideration (see H. Res. 451), H6117 [10JN]

———authorizing appropriations (H.R. 3603), consideration of conference report (see H. Res. 496), H9565 [31JY]

Animal Welfare Act: amend and strengthen (see H.R. 4249), H11526 [27SE]

Board of Tea Experts: abolish (see S. 1518; H.R. 2969), S98 [5JA], H1251 [23FE]

———abolish (S. 1518), return to Senate (see H. Res. 387), H2665 [21MR]

Breast implants: require full documentation of information (see H. Res. 449, 527), H6005 [6JN], H10721 [19SE]

Drugs: classification of certain dietary supplements (see S. 1806), S5567 [23MY]

———defer effective dates for approving certain drug applications (see S. 2178; H.R. 4277), S11973 [30SE], H12172 [28SE]

Federal Food, Drug and Cosmetic Act: certification of drugs containing insulin and antibiotics (see H.R. 3672), H6509 [18JN]

Food: increase access to nutritional information and increase availability of safe food products (see H.R. 3200), H3229 [29MR]

Government regulations: approval process and development of new drugs and biological products (see H.R. 3199), H3229 [29MR]

Health: allow marketing of Sensor Pad medical device to aid in breast self-examination (see H.R. 3504), H5500 [22MY]

Health care professionals: facilitate the dissemination to physicians of scientific information on drug therapies and medical devices (see H.R. 2932), H1224 [1FE]

Medical devices: facilitate the development and approval process (see H.R. 3201), H3229 [29MR]

Patents: extend protection for certain pipeline drugs (see S. 2154), S11720 [28SE]

Persian Gulf Conflict: review procedures for funding of certain medical research relative to illnesses suffered by veterans (see H.R. 3288), H3730 [23AP]

Pharmaceuticals: reinstate reasonable pricing requirements for drugs developed with Federal funding or research and establish minimum levels of research reinvestment for drug manufacturers (see H.R. 4270), H11527 [27SE]

Tobacco products: limit advertising over the Internet (see S. 2184), S12125 [1OC]

Water: labeling requirements for bottled drinking water (see H.R. 3944), H9705 [1AU]

Conference reports

Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations (H.R. 3603), H9368-H9378 [30JY]

Documents

Sales of Tobacco Products to Children: Smoke-Free Class of 2000 (organization), H6235 [12JN]

Letters

Bottled drinking water standards: Sylvia E. Swanson, International Bottled Water Association, H9869, H9876 [2AU]

Environmental tobacco smoke relative to lung cancer: Daniel P. Mulhollan, Congressional Research Service, S11638 [28SE]

FDA approval process of new medical devices and new drugs: Jeffrey N. South, H2307 [14MR]

GATT implementation relative to generic drug industry: C. Everett Koop, S7120 [27JN]

———William E. Brock III, Brock Group, Ltd., S7120 [27JN]

GATT implementation relative to the generic drug industry: Cathy L. Hurwit, Citizen Action (organization), S3581 [18AP]

———Cynthia Pearson, National Women's Health Network, S3580 [18AP]

———Dixie D. Horning, S3581 [18AP]

———Generic Drug Equity Coalition, S3581 [18AP]

———Martha A. McSteen, National Committee To Preserve Social Security and Medicare, S3580 [18AP]

———Mern Horan, Consumer Federation of America, S3581 [18AP]

———Thair Phillips, Seniors Coalition, S3580 [18AP]

———Theresa Amato, Citizen Advocacy Center, S3581 [18AP]

Regulation of tobacco industry: Senator Lautenberg, S1158 [7FE]

Regulation of tobacco industry to alleviate health risks to children: Lawton C. Chiles, Governor of Florida, S11564 [27SE]

Sales of tobacco products to children: Sarah Weller, H6235 [12JN]

Lists

Examples of Arkansas patents granted extensions under GATT, S7119 [27JN]

Petitions and memorials

Georgia: FDA regulatory powers over tobacco industry, E362 [14MR]

Remarks in House

Agriculture: research programs funding, H6166, H6167 [11JN]

Agriculture, rural development, FDA, and related agencies programs: authorizing appropriations, H5766 [4JN]

———authorizing appropriations (H.R. 3603), H6164 [11JN], H6191-H6247 [12JN], E1062, E1065, E1075 [12JN], E1086, E1088 [13JN]

———authorizing appropriations (H.R. 3603), conference report, H9715, H9723, H9724 [1AU]

———authorizing appropriations (H.R. 3603), consideration (H. Res. 451), H6159-H6164-H6182 [11JN]

Animal Welfare Act: amend and strengthen (H.R. 4249), E1767 [27SE]

Animals: improve animal drug approval process (H.R. 2508), H10835-H10841 [24SE]

Board of Tea Experts: abolish (H.R. 2969), H2577 [21MR], H2846 [26MR]

———abolish (S. 1518), return to Senate (H. Res. 387), H2577 [21MR]

Breast implants: require full documentation of information (H. Res. 449), E1032 [7JN]

Dept. of Agriculture: future studies and evaluations funding, H6176, H6177 [11JN]

Drugs: approval of home drug testing kit for use by parents, H11233 [26SE]

———approval of RU-486, H9457 [31JY]

Food: increase access to nutritional information and increase availability of safe food products (H.R. 3200), H5632-H5639 [29MY], E676 [1MY]

———safety, E734 [8MY]

Foreign trade: expand authority for the export of drugs or medical devices (H.R. 1300), H4094 [25AP]

Funding, E1190 [27JN]

Government regulations: approval process and development of new drugs and biological products (H.R. 3199), H5632-H5639 [29MY], E676 [1MY]

———approval process and regulations relative to new medical devices and new drugs, H2306 [14MR]

Health: accessibility of alternative treatments and medicines (H.R. 2019), H4115 [29AP]

———allow marketing of Sensor Pad medical device to aid in breast self-examination, H6169 [11JN]

———allow marketing of Sensor Pad medical device to aid in breast self-examination (H.R. 3504), H5386, H5387 [22MY]

Health care professionals: facilitate the dissemination to physicians of scientific information on drug therapies and medical devices (H.R. 2932), E173 [5FE]

Hispanic Women's Health Conference: convene, E695 [1MY]

Medical devices: facilitate the development and approval process (H.R. 3201), H5632-H5639 [29MY], E676 [1MY]

Mexico: modification of quarantine on Mexican Hass avocados, E1065 [12JN]

Pharmaceuticals: improve the regulation of drugs (H.R. 1995), H2464 [19MR]

———reinstate reasonable pricing requirements for drugs developed with Federal funding or research and establish minimum levels of research reinvestment for drug manufacturers (H.R. 4270), E1788 [28SE]

Reform, H2931 [27MR], H2968 [28MR], H3571, H3572 [17AP]

Tobacco products: Federal regulations, H5571 [29MY]

———prohibit regulation of tobacco industry, E362 [14MR]

———regulation of tobacco industry to alleviate health risks to children, H915 [26JA], H9929 [4SE], H10180 [11SE], E90, E96, E102 [25JA], E148, E172 [5FE], E989 [4JN], E1863 [30SE]

Water: modify bottled drinking water standards, H6755 [25JN], H9868, H9875 [2AU]

Remarks in Senate

Agriculture, rural development, FDA, and related agencies programs: authorizing appropriations (H.R. 3603), S8435, S8454-S8465, S8485, S8487, S8491 [22JY], S8532-S8552 [23JY], S8583-S8600, S8602-S8617 [24JY], S8927 [25JY]

———authorizing appropriations (H.R. 3603), conference report, S9334-S9337, S9425 [1AU], S9634 [2AU], S11697, S11763 [28SE]

———authorizing appropriations (H.R. 3603), conference report—unanimous-consent agreement, S9275 [31JY]

———authorizing appropriations (H.R. 3603), unanimous-consent agreement, S8537 [23JY]

Animals: improve animal drug approval process (H.R. 2508), S11326 [25SE]

———improve animal drug approval process (S. 773), S11204-S11209 [24SE]

Board of Tea Experts: abolish (H.R. 2969), S2838 [25MR]

———abolish (S. 1518), S108 [5JA], S724 [1FE]

Drugs: classification of certain dietary supplements (S. 1806), S5582-S5584 [23MY]

———defer effective dates for approving certain drug applications (S. 2178), S11992 [30SE]

———patent protection for arthritis medication Lodine, S9457, S9458, S9463-S9466, S9469, S9499-S9501 [2AU]

———review of generic drug applications, S8546 [23JY]

Foreign trade: expand authority for the export of drugs or medical devices, S2173-S2177 [15MR]

GATT: implementation relative to generic drug industry, S3133, S3134 [28MR], S3215 [29MR], S3574, S3578-S3583 [18AP], S6460 [19JN], S6591-S6603 [20JN], S6827 [25JN], S7115-S7125 [27JN]

———implementation relative to generic drugs, S2038 [14MR]

Government regulations: improve regulation of food, drugs, devices, and biological products (S. 1477), S9552 [2AU]

Patents: extend protection for certain pipeline drugs (S. 2154), S11720-S11722 [28SE]

Pharmaceuticals: patent litigation relative to ranitidine, S2085 [14MR]

———regulation of prescription drug industry, S8457 [22JY], S8594-S8600, S8609-S8612 [24JY], S9336, S9337 [1AU]

Proctor & Gamble Co.: petition for use of olestra as a food additive, S70 [4JA]

Reform, S8605, S8607 [24JY], S12020 [30SE]

Tobacco products: effects of environmental tobacco smoke relative to lung cancer risk, S11638 [28SE]

———limit advertising over the Internet (S. 2184), S12126 [1OC]

———regulation of tobacco industry to alleviate health risks to children, S356 [25JA], S1154 [7FE], S11128, S11197 [24SE], S11318 [25SE], S11443 [26SE], S11562 [27SE]

Water: modify bottled drinking water standards, S9489 [2AU]

Reports filed

Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations: Committee of Conference (H.R. 3603) (H. Rept. 104-726), H8981 [30JY]

———Committee on Appropriations (House) (H.R. 3603) (H. Rept. 104-613), H6040 [7JN]

———Committee on Appropriations (Senate) (H.R. 3603) (S. Rept. 104-317), S7762 [11JY]

Animal Drug Availability Act: Committee on Commerce (House) (H.R. 2508) (H. Rept. 104-822), H11046 [24SE]

Board of Tea Experts Abolishment: Committee on Commerce (House) (H.R. 2969) (H. Rept. 104-467), H2033 [8MR]

———Committee on Ways and Means (House) (H.R. 2969) (H. Rept. 104-467), H1663 [4MR]

Consideration of Conference Report on H.R. 3603, Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations: Committee on Rules (House) (H. Res. 496) (H. Rept. 104-730), H9565 [31JY]

Consideration of H.R. 3603, Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations: Committee on Rules (House) (H. Res. 451) (H. Rept. 104-616), H6117 [10JN]

Food Quality Protection Act: Committee on Commerce (House) (H.R. 1627) (H. Rept. 104-669), H8247 [23JY]

Generic Drug Industry Relief: Committee on the Judiciary (Senate) (S. 1277) (S. Rept. 104-394), S12125 [1OC]

Statements

GATT Implementation Relative to Generic Drug Industry: by, S3134 [28MR]

———Michael Kantor, U.S. Trade Representative, S3215 [29MR]

Regulation of Tobacco Industry To Alleviate Health Risks to Children: Representative Meehan, S11199 [24SE]

———Senator Bingaman, S11199 [24SE]

———Senator Harkin, S11199 [24SE]

———Senator Kennedy, S11198 [24SE]

———Senator Lautenberg, S11198 [24SE]

Summaries

Animal Drug Availability Act (S. 773), S11205 [24SE]

Tables

Agriculture, rural development, FDA, and related agencies programs appropriations (H.R. 3603), S9336 [1AU], H6236-H6243 [12JN], H9716-H9722 [1AU]

Testimonies

Regulation of Tobacco Industry To Alleviate Health Risks to Children: Alan Landers, S11563 [27SE]

———Hubert H. Humphrey III, Attorney General of Minnesota, S11444 [26SE]

———Ian L. Uydess, S11444-S11446 [26SE]

———Janet Sackman, S11564 [27SE]

———Jody Hayes, S11318 [25SE]

———Justin Hoover, S11318 [25SE]

———Martin N. Gordon, S11563 [27SE]

———Morton Downey, Jr., S11562 [27SE]

Texts of

H. Res. 387, return S. 1518 to Senate, Federal Tea Tasters Repeal Act, H2577 [21MR]

H. Res. 451, consideration of H.R. 3603, agriculture, rural development, FDA, and related agencies programs appropriations, H6159 [11JN]

H.R. 2508, Animal Drug Availability Act, H10835-H10838 [24SE]

H.R. 2969, abolish Board of Tea Experts, H2577 [21MR]

H.R. 3603, agriculture, rural development, FDA, and related agencies programs appropriations, S8426-S8435 [22JY]

S. 773, Animal Drug Availability Act, S11207-S11209 [24SE]

S. 1518, Federal Tea Tasters Repeal Act, S724 [1FE]

S. 2154, Pharmaceutical Equity Act, S11722 [28SE]

S. 2184, Tobacco-Free Children's Internet Act, S12126 [1OC]

Transcripts

Brown & Williamson Tobacco Co.'s Disclosure of Information Relative to the Health Effects of Tobacco: ``60 Minutes'' (television program), S1154-S1157 [7FE]